August J. Troendle - Feb 17, 2023 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role: CEO, Director, 10%+ Owner
Signature: /s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
Stock symbol: MEDP
Transactions as of: Feb 17, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/22/2023, 03:46 PM
Previous filing: Sep 23, 2022
Next filing: Apr 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MEDP	Common Stock						6.48M	Feb 17, 2023	By Medpace Investors, LLC	F1
holding	MEDP	Common Stock						807K	Feb 17, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MEDP	Restricted Stock Unit	Award	$0	+1K		$0.00	1K	Feb 17, 2023	Common Stock	1K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F2	Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
F3	The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.